Our development program focuses on new approaches to neurological diseases and disorders.
Our portfolio has a number of compounds with multiple potential indications and multiple targets. This is an ideal portfolio for innovative, experimental medicine techniques, including state-of-the-art imaging tools, to establish rapid proof-of-concept through small, smart clinical trials. This will allow us to find in a cost-effective and efficient manner the best indication for each compound and the best compound for each indication.
Please click on the compounds for further information